New findings provide promise of targeted scleroderma treatment
Researchers have discovered a biodegradable nanoparticle that could combat scleroderma, a rare autoimmune disease.
List view / Grid view
Researchers have discovered a biodegradable nanoparticle that could combat scleroderma, a rare autoimmune disease.
Researchers have discovered two types of cells in the brain that are involved in organising discrete memories based on when they occurred. This finding improves the understanding of how the human brain forms memories and could have implications in memory disorders such as Alzheimer’s disease.
A scientist at the University of Houston receives a $2 million grant to innovate computer-aided drug discovery for breast cancer.
Researchers from the Technical University of Munich have successfully used specific enzymes to destroy the genetic information of SARS-CoV-2 directly after the virus enters a cell.
Researchers have developed a new way to generate breast tumour models faster, more reliably and with less immune variability than existing models.
Researchers have developed a new imaging approach that can capture blood vessel images at different spatial scales.
A study has shown how Parkinson’s disease may be driven by cell stress-related biochemical events that disrupt a key cellular clean-up system.
MIT chemists have discovered a possible way to design drugs that could fight against drug resistance.
Researchers have identified potential age-related macular degeneration drugs using a novel stem-cell based research tool.
New research by the University of California, San Diego could provide a much simpler way to repair disease-causing mutations in RNA.
Researchers have made a respiratory model of COVID-19, made from patient-derived stem cells, to understand how the virus affects respiration and which could be used to test possible drugs.
Using virtual screening, researchers have discovered several natural compounds that could inhibit the SARS-CoV-2 main protease.
A research team based at Skoltech in Russia has developed an artificial intelligence-driven solution for highly accurate detection of efficacious binding sites to expedite drug discovery.
A new platform, named Virtual Synthon Hierarchical Enumeration Screening, has been developed by researchers to efficiently discover drugs.
19 August 2021 | By 10X Genomics
Explore the latest developments in screening technologies and how drug discovery has changed during the past decades in our webinar with 10X Genomics.